UA6306U - Method for treating disorders of hepatic blood circulation in patients with arterial hypertension and heart failure - Google Patents
Method for treating disorders of hepatic blood circulation in patients with arterial hypertension and heart failureInfo
- Publication number
- UA6306U UA6306U UA20040402788U UA20040402788U UA6306U UA 6306 U UA6306 U UA 6306U UA 20040402788 U UA20040402788 U UA 20040402788U UA 20040402788 U UA20040402788 U UA 20040402788U UA 6306 U UA6306 U UA 6306U
- Authority
- UA
- Ukraine
- Prior art keywords
- patients
- heart failure
- blood circulation
- arterial hypertension
- hepatic blood
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title abstract 2
- 208000037849 arterial hypertension Diseases 0.000 title abstract 2
- 230000017531 blood circulation Effects 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000002440 hepatic effect Effects 0.000 title abstract 2
- 239000005541 ACE inhibitor Substances 0.000 abstract 1
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 abstract 1
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 abstract 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 230000001882 diuretic effect Effects 0.000 abstract 1
- 229960000610 enoxaparin Drugs 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The method for treating the disorders of hepatic blood circulation in the patients with the arterial hypertension and the heart failure comprises the use of angiotensin-converting enzyme inhibitor, diuretic, beta-adrenoblocker, and Enoxaparin (Clexan) subcutaneously at a daily dose of 0.5 mg/kg.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA20040402788U UA6306U (en) | 2004-04-15 | 2004-04-15 | Method for treating disorders of hepatic blood circulation in patients with arterial hypertension and heart failure |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA20040402788U UA6306U (en) | 2004-04-15 | 2004-04-15 | Method for treating disorders of hepatic blood circulation in patients with arterial hypertension and heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA6306U true UA6306U (en) | 2005-05-16 |
Family
ID=34882615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA20040402788U UA6306U (en) | 2004-04-15 | 2004-04-15 | Method for treating disorders of hepatic blood circulation in patients with arterial hypertension and heart failure |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA6306U (en) |
-
2004
- 2004-04-15 UA UA20040402788U patent/UA6306U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1500403A4 (en) | Preventive/remedy for diabetes | |
| WO2005049084A3 (en) | Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure | |
| IL157821A0 (en) | Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv | |
| WO2007022101A3 (en) | Treatment of diseases by subcutaneous administration of a vegf antagonist | |
| WO2007002572A3 (en) | Nattokinase for reducing whole blood viscosity | |
| SG148850A1 (en) | Methods of treating vascular disease | |
| WO2004080482A8 (en) | Use of angiotensin converting enzyme (ace) inhibitors to prevent diabetes in a subject with chronic heart failure | |
| SI1437131T1 (en) | Use of ramipril for the prevention of diabetes in a patient with no preexisting congestive heart failure | |
| AU2003222513A1 (en) | Preventing and/or treating vascular disease, cardiomyopathy and/or associated heart failure | |
| MXPA05006399A (en) | Methods and dosage forms for reducing heart attacks in a hypertensive individual with a diuretic or a diuretic and an ace inhibitor combination. | |
| WO2004006849A3 (en) | Combinations of drugs for the treatment of neoplasms | |
| WO2005060960A3 (en) | Use of histamine to treat bone disease | |
| WO2004075856A3 (en) | Adenosine a1 receptor antagonist for the treatment of cardiac and renal diseases | |
| CA2344910A1 (en) | Method for treating renal disease, and pharmaceutical composition for treating renal disease | |
| TW200503666A (en) | Treatment of type 1 diabetes with pde5 inhibitors | |
| UA6306U (en) | Method for treating disorders of hepatic blood circulation in patients with arterial hypertension and heart failure | |
| DE60301862D1 (en) | COMBINATION TREATMENT IN ACUTE MYOKARDINFARKT | |
| NZ514911A (en) | Use of N-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients | |
| WO1999043308A3 (en) | Treating pulmonary hypertension through tenascin suppression and elastase inhibition | |
| WO2003072019A3 (en) | Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog | |
| WO2008021996A8 (en) | Nutritional supplement for increased energy and stamina | |
| IL144621A0 (en) | Use of moxonidine for postmyocardial infarction treatment | |
| EA200000556A1 (en) | METHOD OF PREVENTING CHRONIC HEART FAILURE IN PULMONARY TUBERCULOSIS PATIENTS | |
| WO2004075893A8 (en) | Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin ii receptor blocker | |
| PT1948216E (en) | Treatment of acute renal failure with soluble thrombomodulin |